Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
31,409,972
-
Shares change
-
+9,808,777
-
Total reported value, excl. options
-
$1,264,282,488
-
Value change
-
+$428,860,586
-
Put/Call ratio
-
160%
-
Number of buys
-
55
-
Number of sells
-
-22
-
Price
-
$40.25
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q4 2023
96 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q4 2023.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,409,972 shares
of 53,599,048 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (8,418,093 shares), PERCEPTIVE ADVISORS LLC (3,074,542 shares), Carlyle Group Inc. (2,857,804 shares), Nantahala Capital Management, LLC (2,856,351 shares), JANUS HENDERSON GROUP PLC (2,523,897 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,826,814 shares), Vestal Point Capital, LP (1,300,000 shares), VANGUARD GROUP INC (969,622 shares), BALYASNY ASSET MANAGEMENT L.P. (926,876 shares), and Avoro Capital Advisors LLC (785,000 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.